ANEST IWATA Corp. (6381) AI Stock Analysis

• Market Cap: ¥60.41B
• Dividend Yield: 2.98%
• Average Volume (3M): 80.39K
• Price to Earnings (P/E): 14.5
• Beta (1Y): 0.72
• Revenue Growth: -1.67%
• EPS Growth: -4.39%
• Country: JP
• Employees: 1,865
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 32.12
• Shares Outstanding: 41,745,502
• 10 Day Avg. Volume: 57,960
• 30 Day Avg. Volume: 80,393
• PEG Ratio: -0.92
• Price to Book (P/B): 0.96
• Price to Sales (P/S): 0.83
• P/FCF Ratio: 6.37
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ¥1,718.00 ▲(14.53% Upside)

ANEST IWATA Corp. demonstrates strong financial performance with solid revenue growth and profitability, supported by a robust balance sheet. While technical indicators suggest some short-term weakness, the stock's valuation remains attractive with a reasonable P/E ratio and a good dividend yield. The absence of recent earnings call data and corporate events does not impact the overall assessment.

ANEST IWATA Corp. Business Overview & Revenue Model

Company Description

ANEST IWATA Corporation engages in the air energy and coating businesses in Japan and internationally. The company offers air compressors and nitrogen gas generators for various applications, such as factories, food production, hospitals, electric buses and new transportation systems, etc.; oil-free scroll vacuum pumps used in general industries, semiconductor manufacturing, food production, accelerators and synchrotron radiation facilities, etc.; steam power generators; spray guns, electrostatic coating machines, and paint supply equipment for industrial coating and automotive refinishing markets; and automatic painting devices, painting plants, painting robots, environmental devices, and painting booths. It also provides adhesive machinery, equipment, and systems; medical equipment; power supply units and power transmission devices. In addition, the company engages in the generation and sale of power derived from natural renewable energy. ANEST IWATA Corporation was founded in 1926 and is headquartered in Yokohama, Japan.

How the Company Makes Money

ANEST IWATA generates revenue through the sale of its extensive product lineup, which includes spray equipment, pumps, and compressors. The company benefits from a diversified customer base across multiple sectors, including automotive and industrial manufacturing. Key revenue streams include direct sales of products, aftermarket services, and maintenance contracts. Additionally, ANEST IWATA has established partnerships with various distributors and manufacturers, which help to expand its market reach and drive sales. The company's commitment to innovation and quality also contributes to customer loyalty and repeat business, further enhancing its revenue potential.

ANEST IWATA Corp. Financial Statement Overview

Summary

ANEST IWATA Corp. exhibits solid financial health with strong revenue growth, profitability, and cash flow generation. The company is well-positioned with a strong balance sheet characterized by low leverage and a high equity ratio, reducing financial risk. Continued focus on efficient operations and cash flow management will further enhance its financial strength.

Income Statement

ANEST IWATA Corp. shows a strong gross profit margin of 46.54% for the most recent year. The net profit margin for the same period is 7.86%, indicating effective cost control. Revenue growth has been consistent, with a 1.85% increase from the previous year. EBIT and EBITDA margins are solid at 10.85% and 18.13%, respectively, highlighting efficient operations and strong earnings before interest, tax, depreciation, and amortization.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.06, implying low financial leverage and risk. The return on equity stands at 9.13%, reflecting good profitability relative to equity. An equity ratio of 67.70% indicates a strong capital structure, with significant equity financing supporting overall financial stability.

Cash Flow

ANEST IWATA Corp. reports a robust free cash flow growth rate of 53.83% year-over-year, demonstrating efficient cash generation. An operating cash flow to net income ratio of 2.28 signifies strong cash flow from operations relative to net income. The free cash flow to net income ratio is 1.66, indicating healthy cash flow available after capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	54.02B	54.41B	53.42B	48.52B	42.34B	35.59B
Gross Profit	25.43B	25.32B	24.48B	21.34B	18.23B	14.93B
EBITDA	10.01B	9.86B	10.31B	9.23B	7.36B	5.83B
Net Income	4.12B	4.28B	4.93B	4.38B	3.54B	2.62B
Balance Sheet
Total Assets	67.14B	69.20B	66.14B	60.14B	55.82B	49.46B
Cash, Cash Equivalents and Short-Term Investments	18.84B	21.34B	16.93B	14.51B	14.32B	13.20B
Total Debt	2.78B	2.87B	3.07B	2.67B	2.42B	2.47B
Total Liabilities	15.13B	15.64B	16.07B	14.88B	15.61B	13.32B
Stockholders Equity	45.95B	46.85B	44.16B	40.03B	35.62B	32.24B
Cash Flow
Free Cash Flow	0.00	7.08B	4.60B	2.16B	2.45B	3.84B
Operating Cash Flow	0.00	9.75B	6.77B	4.33B	3.89B	4.60B
Investing Cash Flow	0.00	-3.25B	-1.26B	-3.32B	-1.08B	-1.07B
Financing Cash Flow	0.00	-3.93B	-3.58B	-2.36B	-2.10B	-1.96B

ANEST IWATA Corp. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1500.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Negative. The current price of 1500 is below the 20-day moving average (MA) of 1531.15, below the 50-day MA of 1548.92, and above the 200-day MA of 1364.95, indicating a neutral trend. The MACD of -12.10 indicates Positive momentum. The RSI at 42.28 is Neutral, neither overbought nor oversold. The STOCH value of 56.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6381.

ANEST IWATA Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6517	79 Outperform	¥56.68B	12.05	―	2.91%	-6.00%	-13.74%
6237	76 Outperform	¥55.81B	12.83	―	2.79%	2.85%	3.17%
6381	75 Outperform	¥60.41B	14.54	―	2.98%	-1.67%	-4.39%
6333	72 Outperform	¥47.27B	10.77	―	4.11%	1.72%	101.76%
6364	71 Outperform	¥55.15B	12.16	―	2.98%	2.98%	10.15%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
6363	62 Neutral	¥50.11B	14.29	―	3.20%	6.35%	-34.20%

ANEST IWATA Corp. Corporate Events

ANEST IWATA Enhances Board Effectiveness for Sustainable Growth

ANEST IWATA Corporation has completed its annual evaluation of the effectiveness of its Board of Directors for FY2024, aiming to improve corporate governance and achieve sustainable growth. The evaluation identified ongoing issues such as the need for enhanced training programs for future management candidates and improved communication and deliberation processes. The company plans to address these issues by refining its training programs and ensuring more efficient board deliberations, which are expected to strengthen its strategic positioning and stakeholder engagement.

The most recent analyst rating on (JP:6381) stock is a Buy with a Yen1729.00 price target. To see the full list of analyst forecasts on ANEST IWATA Corp. stock, see the JP:6381 Stock Forecast page.

ANEST IWATA Reports Decline in FY2025 Q1 Profits Amid Market Challenges

ANEST IWATA Corporation reported a decline in net sales and profits for the first quarter of FY2025, with a notable drop in the air energy business due to weak demand in China. The coating business saw increased profits despite declining sales, attributed to improved marketing in China. Overall, the company faced challenges with increased SG&A expenses and reduced foreign exchange gains, impacting its ordinary and operating profits.

ANEST IWATA Reports Decline in Q1 FY2025 but Projects Recovery

ANEST IWATA Corporation reported a decline in its financial performance for the first quarter of FY2025, with net sales dropping by 3.2% and operating profit decreasing by 8.7% compared to the previous year. Despite the downturn, the company forecasts a recovery in the second half of the year, projecting a 6.6% increase in net sales for the full fiscal year, indicating a potential rebound in its market position.